Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 88 entries
Sorted by: Best Match Show Resources per page
Increasing teachers' use of a 1: 1 praise‐to‐behavior correction ratio to decrease student disruption in general education classrooms

classroom interventions

Connell JE, Tincani M.
GSID: qSda9NYCokEJ
J Pisacreta, M Tincani, JE Connell… - Behavioral …, 2011 - Wiley Online Library

Contingent, behavior‐specific praise is universally recommended as an effective tool to increase students' academic achievement and proscocial behavior. Despite this …

Gastrointestinal-associated autoantibodies in different autoimmune diseases.

American journal of clinical and experimental immunology

Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y.
PMID: 23885314
Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012.

BACKGROUND: Gastrointestinal (GI)-related autoantibodies (Abs) are rarely evaluated in autoimmune diseases (AID) other than inflammatory bowel disease, autoimmune hepatitis and celiac disease. Our aim was to determine the prevalence of these antibodies in a wide spectrum of AID.METHODS: We...

Cite
Shor DB, Orbach H, Boaz M, et al. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012;1(1):49-55
Shor, D. B., Orbach, H., Boaz, M., Altman, A., Anaya, J. M., Bizzaro, N., Tincani, A., Cervera, R., Espinosa, G., Stojanovich, L., Rozman, B., Bombardieri, S., Vita, S. D., Damoiseaux, J., Villalta, D., Tonutti, E., Tozzoli, R., Barzilai, O., Ram, M., Blank, M., Agmon-Levin, N., & Shoenfeld, Y. (2012). Gastrointestinal-associated autoantibodies in different autoimmune diseases. American journal of clinical and experimental immunology, 1(1), 49-55.
Shor, Dana Ben-Ami, et al. "Gastrointestinal-associated autoantibodies in different autoimmune diseases." American journal of clinical and experimental immunology vol. 1,1 (2012): 49-55.
Shor DB, Orbach H, Boaz M, Altman A, Anaya JM, Bizzaro N, Tincani A, Cervera R, Espinosa G, Stojanovich L, Rozman B, Bombardieri S, Vita SD, Damoiseaux J, Villalta D, Tonutti E, Tozzoli R, Barzilai O, Ram M, Blank M, Agmon-Levin N, Shoenfeld Y. Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol. 2012 May 25;1(1):49-55. Print 2012. PMID: 23885314; PMCID: PMC3714189.
Copy Download .nbib Format: NLM
'Making every contact count': Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change.

Journal of health psychology

Lawrence W, Black C, Tinati T, Cradock S, Begum R, Jarman M, Pease A, Margetts B, Davies J, Inskip H, Cooper C, Baird J, Barker M.
PMID: 24713156
J Health Psychol. 2016 Feb;21(2):138-51. doi: 10.1177/1359105314523304. Epub 2014 Apr 08.

A total of 148 health and social care practitioners were trained in skills to support behaviour change: creating opportunities to discuss health behaviours, using open discovery questions, listening, reflecting and goal-setting. At three time points post-training, use of the...

Cite
Lawrence W, Black C, Tinati T, et al. 'Making every contact count': Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change. J Health Psychol. 2014;21(2):138-51doi: 10.1177/1359105314523304.
Lawrence, W., Black, C., Tinati, T., Cradock, S., Begum, R., Jarman, M., Pease, A., Margetts, B., Davies, J., Inskip, H., Cooper, C., Baird, J., & Barker, M. (2016). 'Making every contact count': Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change. Journal of health psychology, 21(2), 138-51. https://doi.org/10.1177/1359105314523304
Lawrence, Wendy, et al. "'Making every contact count': Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change." Journal of health psychology vol. 21,2 (2016): 138-51. doi: https://doi.org/10.1177/1359105314523304
Lawrence W, Black C, Tinati T, Cradock S, Begum R, Jarman M, Pease A, Margetts B, Davies J, Inskip H, Cooper C, Baird J, Barker M. 'Making every contact count': Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change. J Health Psychol. 2016 Feb;21(2):138-51. doi: 10.1177/1359105314523304. Epub 2014 Apr 08. PMID: 24713156; PMCID: PMC4678584.
Copy Download .nbib Format: NLM
What's the big fuss about 'big data'?.

Journal of health services research & policy

Pope C, Halford S, Tinati R, Weal M.
PMID: 24594859
J Health Serv Res Policy. 2014 Apr;19(2):67-8. doi: 10.1177/1355819614521181. Epub 2014 Mar 04.

No abstract available.

Cite
Pope C, Halford S, Tinati R, et al. What's the big fuss about 'big data'?. J Health Serv Res Policy. 2014;19(2):67-8doi: 10.1177/1355819614521181.
Pope, C., Halford, S., Tinati, R., & Weal, M. (2014). What's the big fuss about 'big data'?. Journal of health services research & policy, 19(2), 67-8. https://doi.org/10.1177/1355819614521181
Pope, Catherine, et al. "What's the big fuss about 'big data'?." Journal of health services research & policy vol. 19,2 (2014): 67-8. doi: https://doi.org/10.1177/1355819614521181
Pope C, Halford S, Tinati R, Weal M. What's the big fuss about 'big data'?. J Health Serv Res Policy. 2014 Apr;19(2):67-8. doi: 10.1177/1355819614521181. Epub 2014 Mar 04. PMID: 24594859.
Copy Download .nbib Format: NLM
Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma.

Cells

Tincati C, Cappione Iii AJ, Snyder-Cappione JE.
PMID: 24710416
Cells. 2012 May 07;1(2):89-99. doi: 10.3390/cells1020089.

Mycobacterium tuberculosis (MTB) is a global heath epidemic, its threat amplified by HIV infection and the emergence of multidrug-resistant tuberculosis (MDR-TB). Interferon (IFN)-gamma release assays (IGRAs) have improved the accuracy of detection of MTB exposure in some subject groups...

Cite
Tincati C, Cappione Iii AJ, Snyder-Cappione JE. Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma. Cells. 2012;1(2):89-99doi: 10.3390/cells1020089.
Tincati, C., Cappione Iii, A. J., & Snyder-Cappione, J. E. (2012). Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma. Cells, 1(2), 89-99. https://doi.org/10.3390/cells1020089
Tincati, Camilla, et al. "Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma." Cells vol. 1,2 (2012): 89-99. doi: https://doi.org/10.3390/cells1020089
Tincati C, Cappione Iii AJ, Snyder-Cappione JE. Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma. Cells. 2012 May 07;1(2):89-99. doi: 10.3390/cells1020089. PMID: 24710416; PMCID: PMC3901089.
Copy Download .nbib Format: NLM
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Auto- immunity highlights

Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, Roggenbuck D, Tincani A.
PMID: 29845583
Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0.

PURPOSE: Anti-phospholipid antibodies (aPL) analyzed by line immunoassay (LIA) can recognize betaMETHODS: Thirty-four APS patients (14 arterial/venous thrombosis, 16 pregnancy morbidity, and 4 both), 41 patients with SARD lacking clinical APS criteria but demonstrating positivity for anti-βRESULTS: Comparison of...

Cite
Nalli C, Somma V, Andreoli L, et al. Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto Immun Highlights. 2018;9(1):6doi: 10.1007/s13317-018-0106-0.
Nalli, C., Somma, V., Andreoli, L., Büttner, T., Schierack, P., Mahler, M., Roggenbuck, D., & Tincani, A. (2018). Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto- immunity highlights, 9(1), 6. https://doi.org/10.1007/s13317-018-0106-0
Nalli, Cecilia, et al. "Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases." Auto- immunity highlights vol. 9,1 (2018): 6. doi: https://doi.org/10.1007/s13317-018-0106-0
Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, Roggenbuck D, Tincani A. Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto Immun Highlights. 2018 May 29;9(1):6. doi: 10.1007/s13317-018-0106-0. PMID: 29845583; PMCID: PMC5975024.
Copy Download .nbib Format: NLM
Antiphospholipid syndrome: state of the art on clinical practice guidelines.

RMD open

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.
PMID: 30402272
RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN...

Cite
Limper M, Scirè CA, Talarico R, et al. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000785doi: 10.1136/rmdopen-2018-000785.
Limper, M., Scirè, C. A., Talarico, R., Amoura, Z., Avcin, T., Basile, M., Burmester, G., Carli, L., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Dörner, T., Fonseca, J. E., Galetti, I., Hachulla, E., Launay, D., Lourenco, F., Macieira, C., Meroni, P., Montecucco, C. M., Moraes-Fontes, M. F., Mouthon, L., Nalli, C., Ramoni, V., Tektonidou, M., van Laar, J. M., Bombardieri, S., Schneider, M., Smith, V., Vieira, A., Cutolo, M., Mosca, M., & Tincani, A. (2018). Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD open, 4e000785. https://doi.org/10.1136/rmdopen-2018-000785
Limper, Marteen, et al. "Antiphospholipid syndrome: state of the art on clinical practice guidelines." RMD open vol. 4 (2018): e000785. doi: https://doi.org/10.1136/rmdopen-2018-000785
Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4:e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018. PMID: 30402272; PMCID: PMC6203101.
Copy Download .nbib Format: NLM
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Frontiers in cardiovascular medicine

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.
PMID: 30873413
Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

No abstract available.

Cite
Fredi M, Andreoli L, Bacco B, et al. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Front Cardiovasc Med. 2019;6:11doi: 10.3389/fcvm.2019.00011.
Fredi, M., Andreoli, L., Bacco, B., Bertero, T., Bortoluzzi, A., Breda, S., Cappa, V., Ceccarelli, F., Cimaz, R., De Vita, S., Di Poi, E., Elefante, E., Franceschini, F., Gerosa, M., Govoni, M., Hoxha, A., Lojacono, A., Marozio, L., Mathieu, A., Meroni, P. L., Minniti, A., Mosca, M., Muscarà, M., Padovan, M., Piga, M., Priori, R., Ramoni, V., Ruffatti, A., Tani, C., Tonello, M., Trespidi, L., Zatti, S., Calza, S., Tincani, A., & Brucato, A. (2019). First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Frontiers in cardiovascular medicine, 611. https://doi.org/10.3389/fcvm.2019.00011
Fredi, Micaela, et al. "First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)." Frontiers in cardiovascular medicine vol. 6 (2019): 11. doi: https://doi.org/10.3389/fcvm.2019.00011
Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019. PMID: 30873413; PMCID: PMC6404544.
Copy Download .nbib Format: NLM
Systematic Review of Verbal Operants in Speech Generating Device Research from Skinner's Analysis of Verbal Behavior.

Perspectives on behavior science

Tincani M, Miller J, Lorah ER, Nepo K.
PMID: 32647788
Perspect Behav Sci. 2020 Mar 25;43(2):387-413. doi: 10.1007/s40614-020-00243-1. eCollection 2020 Jun.

Skinner's (1957) book

Cite
Tincani M, Miller J, Lorah ER, et al. Systematic Review of Verbal Operants in Speech Generating Device Research from Skinner's Analysis of Verbal Behavior. Perspect Behav Sci. 2020;43(2):387-413doi: 10.1007/s40614-020-00243-1.
Tincani, M., Miller, J., Lorah, E. R., & Nepo, K. (2020). Systematic Review of Verbal Operants in Speech Generating Device Research from Skinner's Analysis of Verbal Behavior. Perspectives on behavior science, 43(2), 387-413. https://doi.org/10.1007/s40614-020-00243-1
Tincani, Matt, et al. "Systematic Review of Verbal Operants in Speech Generating Device Research from Skinner's Analysis of Verbal Behavior." Perspectives on behavior science vol. 43,2 (2020): 387-413. doi: https://doi.org/10.1007/s40614-020-00243-1
Tincani M, Miller J, Lorah ER, Nepo K. Systematic Review of Verbal Operants in Speech Generating Device Research from Skinner's Analysis of Verbal Behavior. Perspect Behav Sci. 2020 Mar 25;43(2):387-413. doi: 10.1007/s40614-020-00243-1. eCollection 2020 Jun. PMID: 32647788; PMCID: PMC7316899.
Copy Download .nbib Format: NLM
Systemic lupus erythematosus: state of the art on clinical practice guidelines.

RMD open

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
PMID: 30564454
RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018.

Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-remitting course. The aim of the present work was to identify current available clinical practice guidelines (CPGs)...

Cite
Tamirou F, Arnaud L, Talarico R, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793doi: 10.1136/rmdopen-2018-000793.
Tamirou, F., Arnaud, L., Talarico, R., Scirè, C. A., Alexander, T., Amoura, Z., Avcin, T., Bortoluzzi, A., Cervera, R., Conti, F., Cornet, A., Devilliers, H., Doria, A., Frassi, M., Fredi, M., Govoni, M., Houssiau, F., Lladò, A., Macieira, C., Martin, T., Massaro, L., Moraes-Fontes, M. F., Pamfil, C., Paolino, S., Tani, C., Tas, S. W., Tektonidou, M., Tincani, A., Van Vollenhoven, R. F., Bombardieri, S., Burmester, G., Eurico, F. J., Galetti, I., Hachulla, E., Mueller-Ladner, U., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Costedoat-Chalumeau, N. (2018). Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD open, 4(2), e000793. https://doi.org/10.1136/rmdopen-2018-000793
Tamirou, Farah, et al. "Systemic lupus erythematosus: state of the art on clinical practice guidelines." RMD open vol. 4,2 (2018): e000793. doi: https://doi.org/10.1136/rmdopen-2018-000793
Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. PMID: 30564454; PMCID: PMC6269635.
Copy Download .nbib Format: NLM
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies.

Biomedicines

Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni MG, Bitsadze V, Calligaro A, Canti V, Caporali R, Carubbi F, Chighizola CB, Conigliaro P, Conti F, De Carolis C, Del Ross T, Favaro M, Gerosa M, Iuliano A, Khizroeva J, Makatsariya A, Meroni PL, Mosca M, Padovan M, Perricone R, Rovere-Querini P, Sebastiani GD, Tani C, Tonello M, Truglia S, Zucchi D, Franceschini F, Tincani A.
PMID: 34208130
Biomedicines. 2021 Jun 11;9(6). doi: 10.3390/biomedicines9060671.

Antiphospholipid antibodies (aPL) can induce fetal loss in experimental animal models. Human studies did find hypocomplementemia associated with pregnancy complications in patients with antiphospholipid syndrome (APS), but these results are not unanimously confirmed. To investigate if the detection of...

Cite
Nalli C, Lini D, Andreoli L, et al. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. Biomedicines. 2021;9(6)doi: 10.3390/biomedicines9060671.
Nalli, C., Lini, D., Andreoli, L., Crisafulli, F., Fredi, M., Lazzaroni, M. G., Bitsadze, V., Calligaro, A., Canti, V., Caporali, R., Carubbi, F., Chighizola, C. B., Conigliaro, P., Conti, F., De Carolis, C., Del Ross, T., Favaro, M., Gerosa, M., Iuliano, A., Khizroeva, J., Makatsariya, A., Meroni, P. L., Mosca, M., Padovan, M., Perricone, R., Rovere-Querini, P., Sebastiani, G. D., Tani, C., Tonello, M., Truglia, S., Zucchi, D., Franceschini, F., & Tincani, A. (2021). Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. Biomedicines, 9(6), . https://doi.org/10.3390/biomedicines9060671
Nalli, Cecilia, et al. "Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies." Biomedicines vol. 9,6 (2021). doi: https://doi.org/10.3390/biomedicines9060671
Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni MG, Bitsadze V, Calligaro A, Canti V, Caporali R, Carubbi F, Chighizola CB, Conigliaro P, Conti F, De Carolis C, Del Ross T, Favaro M, Gerosa M, Iuliano A, Khizroeva J, Makatsariya A, Meroni PL, Mosca M, Padovan M, Perricone R, Rovere-Querini P, Sebastiani GD, Tani C, Tonello M, Truglia S, Zucchi D, Franceschini F, Tincani A. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. Biomedicines. 2021 Jun 11;9(6). doi: 10.3390/biomedicines9060671. PMID: 34208130; PMCID: PMC8230784.
Copy Download .nbib Format: NLM
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis.

Journal of the American Society of Nephrology : JASN

Angeletti A, Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d'Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Ravelli A, Ghiggeri GM.
PMID: 34599042
J Am Soc Nephrol. 2021 Oct 01; doi: 10.1681/ASN.2021050659. Epub 2021 Oct 01.

No abstract available.

Cite
Angeletti A, Bruschi M, Moroni G, et al. Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. J Am Soc Nephrol. 2021;doi: 10.1681/ASN.2021050659.
Angeletti, A., Bruschi, M., Moroni, G., Sinico, R. A., Franceschini, F., Fredi, M., Vaglio, A., Cavagna, L., Petretto, A., Pratesi, F., Migliorini, P., Locatelli, F., Pazzola, G., Pesce, G., Bagnasco, M., Manfredi, A., Ramirez, G. A., Esposito, P., Murdaca, G., Negrini, S., Cipriani, L., Trezzi, B., Emmi, G., Cavazzana, I., Binda, V., d'Alessandro, M., Fenaroli, P., Pisani, I., Garibotto, G., Montecucco, C., Santoro, D., Scolari, F., Volpi, S., Mosca, M., Tincani, A., Candiano, G., Prunotto, M., Verrina, E., Ravelli, A., & Ghiggeri, G. M. (2021). Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. Journal of the American Society of Nephrology : JASN, . https://doi.org/10.1681/ASN.2021050659
Angeletti, Andrea, et al. "Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis." Journal of the American Society of Nephrology : JASN vol. (2021). doi: https://doi.org/10.1681/ASN.2021050659
Angeletti A, Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d'Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Ravelli A, Ghiggeri GM. Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. J Am Soc Nephrol. 2021 Oct 01; doi: 10.1681/ASN.2021050659. Epub 2021 Oct 01. PMID: 34599042; PMCID: PMC8638388.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 88 entries